Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jan 26, 2026 (9 months ago)

Trazodone Hydrochloride

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Tablets/Capsules

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

Affected NDC 70010-0231-01

Compare with the code on your package — it is the most precise check available.

Drug: Trazodone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Trazodone Hydrochloride
NDC 70010-0231
50 mg/1 Tablet
Oral
Granules Pharmaceuticals Inc. Rx
Recalling firm
Granules Pharmaceuticals Inc.
NDC code
70010-231-01
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0305-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Trazodone recalls

See all
Class III · Low risk

traZODONE Hydrochloride Tablets

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Ongoing Failed specification Zydus Pharmaceuticals (USA) Inc NDC 68382-806-10 D-0247-2026
Class II · Moderate risk

Trazodone HCl active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-940-2015

Other recalls by Granules Pharmaceuticals Inc.

All 2026 recalls